Lelia Adelina Paunescu

Lelia Adelina Paunescu has over 25 years of extensive experience in global clinical trials, specializing in various device trials, IVDs, and drug combinations. Currently serving as Head of Clinical Operations at Fractyl Health since April 2024, Lelia is adept in developing clinical strategies for regulatory submissions, including IDE, PMA, and 510(K). Lelia has held significant roles as a Strategic Advisor at MEDIcept Inc. and as Co-Founder and CEO of Kliniq, while previously leading clinical operations at multiple companies including HeartWare Inc. and TransMedics, Inc. Educationally, Lelia earned a PhD in Biophysics from the University of Illinois Urbana-Champaign and an MS in Physics from the University of Bucharest.